The FDA is alerting the public about Chinese weight-loss products, Chaso (Jianfei) Diet Capsules and Chaso Genpi, because they pose a possible public health risk.
The agency is alerting the public to the health risk because several people in Japan are becoming ill, and some have died, after consuming these diet products. chinese diet pills
"FDA is taking this action as a precautionary measure to simply help assure that folks aren't exposed to the potentially dangerous product," said Dr. Lester M. Crawford, FDA Deputy Commissioner.
Products of this kind in many cases are sold in small urban markets as alternatives to Western medicine. In 2001, FDA issued a nationwide alert on the recall of thirteen "Treasure of the East" herbal products due to a dangerous ingredient, aristolochic acid, which can be toxic to the kidney.
The deaths in Japan connected to these Chinese weight-loss products might have resulted from the presence of such active drug ingredients as fenfluramine in the capsules.
Fenfluramine and another diet drug, phentermine, were used in combination for weight reduction until it absolutely was determined that the mixture of drugs was connected to valvulopathy, a significant and sometimes fatal heart disease. Fenfluramine and a chemically similar drug, dexfenfluramine, were taken from the marketplace in 1997. Phentermine, when used alone, has not been connected with valvulopathy and remains on the market.
FDA has advised its import operations personnel to be on the alert for Chaso Diet Capsules and Chaso Genpi. Lida Daidaihua Pills
The agency is urging consumers never to take these diet pills and to notify their local FDA if the products are found in their area.